Portfolio Manager
CurrentLead investor and portfolio manager of investments for strategic venture capital fund. Serve as board observer for 7 private companies and manage investments in publicly-traded entities.
Please complete the CAPTCHA to continue
area 415
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Gus Johnson is listed as Finance & Operations: Alternative Investments | Healthtech + CPG at UT Horizon Fund, based in Denver Metropolitan Area, United States, United States. AeroLeads shows phone signal with area code 415 and a matched LinkedIn profile for Gus Johnson.
Gus Johnson previously worked as Portfolio Manager at Ut Horizon Fund and Board Observer at Astrocyte Pharmaceuticals. Gus Johnson holds Master Of Business Administration - Mba, Finance from Emory University - Goizueta Business School.
This section adds company-level context without repeating Gus Johnson's masked contact details.
Review company-level records connected to Gus Johnson before choosing the right outreach path.
Finance and operations leader with an extensive record of achievement sourcing and exiting investments, procuring funding and directing operations for organizational and portfolio growth. Using deep knowledge and understanding of healthtech and consumer markets to conceptualize and orchestrate critical solutions to drive business objectives, I maintain hands-on involvement in portfolio company operations.
Listed skills include Business Development, Financial Modeling, Strategic Planning, Mergers And Acquisitions, and 30 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Austin, TX, US
Lead investor and portfolio manager of investments for strategic venture capital fund. Serve as board observer for 7 private companies and manage investments in publicly-traded entities.
Groton, Connecticut, US
Astrocyte Pharmaceuticals Inc. is a drug development company dedicated to clinically proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury patients.
Houston, Texas, US
Decisio Health is a health technology company that has developed multiple software systems that provide real-time, secure and accurate patient monitoring capabilities.
Austin, TX, US
MicroTransponder is a medical device company focused on the development and commercialization of neurostimulation devices to treat neurological diseases.
Houston, TX, US
MolecularMatch is a clinical informatics company with expertise in precision oncology, immunotherapy and bioinformatics.
Austin, US
GXC is commercializing a self-interference cancellation solution that enables true full duplex communication for wideband, providing unprecedented low latency symmetric communication. Acquired by Motive Infrastructure November 2024.
Austin, TX, US
Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage decades of leading research in orphan, pulmonary indications for which there are unmet medical needs. Acquired by Aileron Therapeutics (NASDAQ: ALRN) October 2023.
Bellevue, WA, US
Provider of machine-to-machine connectivity software designed to improve the performance of mobile networks. Acquired by Xcom Labs March 2019.
Austin, Texas, US
Accordion Health is a healthcare predictive analytics company that provides targeted guidance using machine learning technologies. Acquired by Evolent Health (NYSE: EVH) June 2017.
Iowa City, IA, US
Led fundraising and startup operations efforts for digital health company commercializing a FDA-approved Class II wearable medical device.
Larkspur, California, US
Developed and executed scalable telemedicine-driven healthtech platform that preceded industry's advancement into remote patient monitoring.
San Mateo, California, US
Served as buy-side credit and equity investor and actively managed portfolio for closed-end investment company that provided growth capital to healthcare and technology companies.
Charlotte, NC, US
Invested debt and equity capital as part of investment banking group's private credit division.
Gaithersburg, Maryland, US
Supported CFO in process to take company public (NYSE: EBS); created corporate operating model and drug development / commercialization forecasts.
Memphis, TN, US
Cognate BioServices is a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapies. Acquired by Charles River Laboratories (NYSE: CRL) April 2021.
St. Petersburg, Florida, US
Raymond James is a diversified financial services company engaged in wealth management, investment banking and asset management.
Quick answers generated from the profile data available on this page.
Gus Johnson works for UT Horizon Fund.
Gus Johnson is listed as Finance & Operations: Alternative Investments | Healthtech + CPG at UT Horizon Fund.
AeroLeads has found 2 phone signal(s) with area code 415 for Gus Johnson at UT Horizon Fund.
Gus Johnson is based in Denver Metropolitan Area, United States, United States while working with UT Horizon Fund.
Gus Johnson has worked for Ut Horizon Fund, Astrocyte Pharmaceuticals, Decisio Health, Inc., Microtransponder, and Molecularmatch.
You can use AeroLeads to view verified contact signals for Gus Johnson at UT Horizon Fund, including work email, phone, and LinkedIn data when available.
Gus Johnson holds Master Of Business Administration - Mba, Finance from Emory University - Goizueta Business School.
Gus Johnson is listed with skills including Business Development, Financial Modeling, Strategic Planning, Mergers And Acquisitions, Management, Private Equity, Corporate Development, and Business Strategy.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts